Unusual Non-Hodgkin's Lymphomas and True Histiocytic Lymphomas

References

• Filippa D A, Lieberman P H, Erlandson R A, et al. A study of malignant lymphomas using light and ultramicroscoplc, cytochemlcal and Immunologic techniques. Correlation with clinical features. Am J Med 1978; 64: 259–268
   PubMed Web of Science ®Google Scholar
• Non-Hodgkin's Lymphoma Pathologic Classification Project National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• NCI Non-Hodgkin's Classification Project Writing Committee. Classification of non-Hodgkin's lymphomas. Reproducibility of major classification systems. Cancer 1985; 55: 91–95
   PubMed Web of Science ®Google Scholar
• Lieberman P H, Filippa D A, Straus D J, Thaler H T, Cirrincione C, Clarkson B D. Evaluation of malignant lymphomas using three classifications and the working formulation. 482 cases with median follow-up of 11.9 years. Am J Med 1986; 81: 365–380
   PubMed Web of Science ®Google Scholar
• Knowles D M, II. Lymphoid cell markers. Their distribution and usefulness in the immuno-phenotypic analysis of lymphoid neoplasms. Am J Surg Pathol 1985; 9(Suppl 3)85–108
   Google Scholar
• Michels S, Swanson P E, Frizzera G, Wick M R. Immunostaining for leukocyte common antigen using an amplified avidin-biotin-peroxidase complex method and paraffin sections. A study of 735 hematopoietic and nonhemato-poietic human neoplasms. Arch Pathol Lab Med 1987; 111: 1035–1039
   PubMed Web of Science ®Google Scholar
• Strickler J G, Weiss L M, Copenhaver C M, et al. Monoclonal antibodies reactive in routinely processed ti sections of malignant lymphoma with emphasis on T-cell lymphomas. Hum Pathol 1987; 18: 808–814
   PubMed Web of Science ®Google Scholar
• Hall P A, D'Ardenne A J, Stansfeld A G. Paraffin section immunohistochemistry. I. Non-Hodgkin's lymphoma. Histopathology 1988; 13: 149–160
   PubMed Web of Science ®Google Scholar
• Hall P A, D'Ardenne A J, Stansfeld A G. Paraffin section immunohistochemistry. II. Hodgkin's disease and large cell anaplastic (kil) lymphoma. Histopathology 1988; 13: 161–169
   PubMed Web of Science ®Google Scholar
• Chan J KC, Ng C S, Hui P K. A simple guide to the terminology and application of leukocyte monoclonal antibodies. Histopathology (review) 1988; 12: 461–480
   PubMed Web of Science ®Google Scholar
• Kostianovsky M, Grimley P M. Ultrastructural findings in the acquired immunodeficiency syndrome (AIDS). Ultrastruct Pathol 1985; 8: 123–130
   PubMed Web of Science ®Google Scholar
• Kostianovsky M, Orenstein J M, Schaff Z, Grimley P M. Cytomembranous inclusions observed in acquired immunodeficiency syndrome. Clinical and experimental review. Arch Pathol Lab Med 1987; 111: 218–223
   PubMed Web of Science ®Google Scholar
• Egerter D A, Beckstead J H. Malignant lymphomas in the acquired immunodeficiency syndrome. Additional evidence for a B-cell origin. Arch Pathol Lab Med 1988; 112: 602–606
   PubMed Web of Science ®Google Scholar
• Presant C A, Gala K, Wiseman C, et al. Human immunodeficiency virus-associated T-cell lymphoblastic lymphoma in AIDS. Cancer 1987; 60: 1459–1461
   PubMedGoogle Scholar
• Fulling K H, Gersell D J. Neoplastic angioen-dotheliomatosis. Histologic, immunohisto-chemical, and ultrastructural findings in two cases. Cancer 1983; 51: 1107–1118
   PubMedGoogle Scholar
• Kitagawa M, Matusbara O, Song S-Y, et al. Neoplastic angioendotheliosis. Immunohisto-chemical and electron microscopic findings in three cases. Cancer 1985; 56: 1134–1143
   PubMed Web of Science ®Google Scholar
• Wrotnowski U, Mills S E, Cooper P H. Malignant angioendotheiiomatosis. An angiotropic lymphoma? Am J Clin Pathol 1985; 83: 244–248
   PubMed Web of Science ®Google Scholar
• Carroll T J, Schelper R L, Goeken J A, Kemp J D. Neoplastic angioendotheiiomatosis: Immuno-pathologic and morphologic evidence for intravascular malignant lymphomatosis. Am J Clin Pathol 1986; 85: 169–175
   PubMed Web of Science ®Google Scholar
• Wick M R, Mills S E, Scheithauer B W, et al. Reassessment of malignant “angioendotheiiomatosis.” Evidence in favor of its reclassification as “intravascular lymphomatous”. Am J Surg Pathol 1986; 10: 112–123
   PubMed Web of Science ®Google Scholar
• Abe S, Shimbo Y, Saito T, et al. An immuno-histochemical study on “neoplastic angioendotheliosis”: Demonstration of B lymphocyte markers in neoplastic cells. Acta Neuropathol (Berl) 1988; 75: 313–316
   PubMed Web of Science ®Google Scholar
• Sibley R, Rosai J, Froehlich W. A case for the panelAnemone cell tumor. Ultrastruct Pathol 1980; 1: 449–453
   PubMed Web of Science ®Google Scholar
• Sibley R, Rosai J, Froehlich W. Anemone cell tumor. Comments by the panel. Ultrastruct Pathol 1985; 8: 369–371
   PubMedGoogle Scholar
• Wirt D P, Nagle R B, Gustafson H M, et al. The probable origin of an anemone cell tumor: Metastatic transitional cell carcinoma producing HCG. Ultrastruct Pathol 1984; 7: 277–288
   PubMed Web of Science ®Google Scholar
• Schwarz R, Marquet E, Sobel H J, Sidhu G S. Another look at the “anemone cell.” Letters to the editor. Ultrastruct Pathol 1982; 3: 209–212
   PubMed Web of Science ®Google Scholar
• Phillips J L, Murray J, Verhaart S. Squamous cell carcinoma with anemone cell features. Ultrastruct Pathol 1987; 11: 47–52
   PubMed Web of Science ®Google Scholar
• Taxy J B, Almanaseer I Y. “Anemone” cell (vili-form) tumors: Electron microscopy and im-munohistochemistry of five cases. Ultrastruct Pathol 1984; 7: 143–150
   PubMed Web of Science ®Google Scholar
• Azar H A, Espinoza C G, Richman A V, Saba S R, Wang T-Y. “Undifferentiated” large cell malignancies: An ultrastructural and immunocyto-chemical study. Hum Pathol 1982; 13: 323–333
   PubMed Web of Science ®Google Scholar
• Bernier V, Azar H A. Filiform large-cell lymphomas. An ultrastructural and immunohisto-chemical study. Am J Surg Pathol 1987; 11: 387–396
   PubMed Web of Science ®Google Scholar
• Osborne B M, Mackay B, Butler J J, Ordonez N G. Large cell lymphoma with microvillus-like projections: An ultrastructural study. Am J Clin Pathol 1983; 79: 443–450
   PubMed Web of Science ®Google Scholar
• Coltman C A, Luce J K, McKelvey E M, et al. Chemotherapy of non-Hodgkin's lymphomas: 10 years experience in the South-West oncology group. Cancer Treat Rep 1977; 61: 1067–1078
   PubMedGoogle Scholar
• Schwab U, Stein H, Gerdes J, et al. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299: 65–67
   PubMed Web of Science ®Google Scholar
• Stein H, Mason D Y, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid ti: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–858
   PubMed Web of Science ®Google Scholar
• Agnarsson B A, Kadin M E. Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol 1988; 12: 264–274
   PubMed Web of Science ®Google Scholar
• Weiss L M, Picker L J, Copenhaver C M, Warnke R A, Sklar J. Large-cell hematolymphoid neoplasms of uncertain lineage. Hum Pathol 1988; 19: 967–973
   PubMed Web of Science ®Google Scholar
• Fujimoto J, Hata J-I, Ishii E, et al. Ki-1 lymphomas in childhood: Immunohistochemical analysis and the significance of epithelial membrane antigen (EMA) as a new marker. Virchows Arch (Pathol Anat) 1988; 412: 307–314
   Google Scholar
• Le Tourneau A, Audouin J, Diebold J. Ultrastructural study of 4 cases of Ki-1 positive large anaplastic cell malignant lymphoma. Virchows Arch (Pathol Anat) 1988; 413: 215–222
   Google Scholar
• Delsol G, Al Saati T, Gatter K C, et al. Coex-pression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis. Am J Pathol 1988; 130: 59–70
   PubMed Web of Science ®Google Scholar
• Rabkin M S, Kjeldsberg C R. Epithelial membrane antigen staining patterns of histiocytic lesions. Arch Pathol Lab Med 1987; 111: 337–338
   PubMedGoogle Scholar
• Wollner N, Exelby P RK, Lieberman P H. Non-Hodgkin's lymphoma in children. A progress report on the original patients treated with the LSA2-L2 protocal. Cancer 1979; 44: 1990–1999
   PubMed Web of Science ®Google Scholar
• Schauer P, Arlin Z A, Mertelsman R, et al. Treatment of acute lymphoblastic leukemia in adults. Results of the L-10 and L-10M proto-cals. J Clin Oncol 1983; 1: 462–470
   PubMed Web of Science ®Google Scholar
• Hanson C A, Jaszcz W, Gajl-Peczalska K J, Kersey J H, Frizzera G. True histiocytic lymphoma: Immunophenotypic and genotypic analysis. Lab Invest 1988; 58: 37A
   PubMedGoogle Scholar
• Turner R R, Wood G S, Beckstead J H, et al. Histiocytic malignancies. Morphologic, immunologic, and enzymatic heterogeneity. Am J Surg Pathol 1984; 8: 485–500
   PubMed Web of Science ®Google Scholar
• Risdall R J, Sibley R K, McKenna R W, Brunning R D, Dehner L P. Malignant histiocytosis. A light- and electron-microscopic and histochem-ical study. Am J Surg Pathol 1980; 4: 439–450
   PubMed Web of Science ®Google Scholar
• Pileri S, Mazza P, Rivano M T, et al. Malignant histiocytosis (true histiocytic lymphoma) clini-copathological study of 25 cases. Histopathol-ogy 1985; 9: 905–920
   PubMed Web of Science ®Google Scholar
• Palatke M, Tabaczka P, Weise R W, et al. T-cell lymphomas of large cell type. A variety of malignant lymphomas: “Histiocytic” and mixed lymphocytic-“histiocytic”. Cancer 1980; 46: 87–101
   PubMedGoogle Scholar
• Isaacson P G. Commentary. Histiocytic malignancy. Histopathology 1985; 9: 1007–1011
   PubMed Web of Science ®Google Scholar
• Gillespie J J. The ultrastructural diagnosis of diffuse large cell (“histiocytic”) lymphoma. Fine structural study of 30 cases. Am J Surg Pathol 1978; 2: 9–20
   PubMed Web of Science ®Google Scholar
• Kuratsune H, Machii T, Aozasa K, et al. B-cell lymphoma showing clinicopathological features of malignant histiocytosis. Acta Haematol 1988; 79: 94–98
   PubMed Web of Science ®Google Scholar
• Lukes R J, Parker J W, Taylor C R, et al. Immunologic approach to non-Hodgkin's lymphomas and related leukemias: Analyses of the results of multiparameter studies of 425 cases. Semin Hematol 1978; 15: 322–351
   PubMed Web of Science ®Google Scholar
• Mirchandani I, Shah I, Palutke M, et al. True histiocytic lymphoma. A report of four cases. Cancer 1983; 52: 1911–1918
   PubMedGoogle Scholar
• Kim H, Pangalis G A, Payne B C, Kadin M E, Rappaport H. Ultrastructural identification of neoplastic histiocytes-monocytes. An application of a newly developed cytochemical techniques. Am J Pathol 1982; 106: 204–223
   PubMedGoogle Scholar
• Roholl P J, Kleyne J, Pijpers H W, van Unnik J AM. Comparative immunohistochemical investigation of markers for malignant histiocytes. Hum Pathol 1985; 16: 763–771
   PubMed Web of Science ®Google Scholar
• Roholl P JM, Kleyne J, Prins M EF, et al. Immunologic marker analysis of normal and malignant histiocytes. A comparative study of monoclonal antibodies for diagnostic purposes. Am J Clin Pathol 1988; 89: 187–194
   PubMed Web of Science ®Google Scholar
• Furukawa F, Taniguchi S, Oguchi M, et al. True histiocytic lymphoma. Arch Dermatol 1980; 116: 915–918
   PubMedGoogle Scholar
• van der Valk P, te Velde J, Lansen J, et al. Malignant lymphoma of true histiocytic origin: Histiocytic sarcoma. A morphological, ultrastructural, immunological, cytochemical and clinical study of 10 cases. Virchows Arch (Pathol Anat) 1981; 391: 249–265
   PubMedGoogle Scholar
• van der Valk P, Meijer C JLM, Willemze R, et al. Histiocytic sarcoma (true histiocytic lymphoma): A clinicopathological study of 20 cases. Histopathology 1984; 8: 105–123
   PubMedGoogle Scholar
• Thomas P, Said J W, Rosenfelt F P, Heifetz L J. True histiocytic lymphoma: An immunohistochemical and ultrastructural study of two cases. Am J Clin Pathol 1984; 81: 243–248
   PubMed Web of Science ®Google Scholar
• Case D C, Jr, Lee B J, III, Clarkson B D. Improved survival times in multiple myeloma treated with melpholan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocal. Am J Med 1977; 63: 897–903
   PubMed Web of Science ®Google Scholar
• Gulati S C, Shank B, Black P, et al. Autologous bone marrow transplantation for patients with poor-prognosis lymphoma. J Clin Oncol 1988; 6: 1303–1313
   PubMed Web of Science ®Google Scholar
• Feltkamp C A, van Heerde P, Feltkamp-Vroom T M, Loudstaal J. A malignant tumor arising from interdigitating cells; light microscopical, ultrastructural, immuno- and enzymatic-histochemical characteristics. Virchows Arch (Pathol Anat) 1981; 393: 183–192
   PubMedGoogle Scholar
• Chan W C, Zaatari G. Lymph node interdigitating reticulum cell sarcoma. Am J Clin Pathol 1986; 85: 739–744
   PubMed Web of Science ®Google Scholar
• van den Oord J J, de Wolf-Peeters C, de Vos R, Thomas J, Desmet V J. Sarcoma arising from interdigitating reticulum cells: Report of a case, studies with light and electron microscopy, and enzyme- and immunohistochemistry. Histopathology 1986; 10: 509–523
   PubMed Web of Science ®Google Scholar
• Nakamura S, Hara K, Suchi T, et al. Interdigitating cell sarcoma. A morphologic, immuno-histologic, and enzyme-histochemical study. Cancer 1988; 61: 562–568
   PubMed Web of Science ®Google Scholar
• Rabkin M S, Kjeldsberg C R, Hammond E, Wit-Twer C T, Nathwani B. Clinical, ultrastructural immunohistochemical and DNA content analysis of lymphomas having features of interdigitating reticulum cells. Cancer 1988; 61: 1594–1601
   PubMed Web of Science ®Google Scholar
• van der Valk P, Ruiter D J, den Ottolander G J, et al. Dendritic reticulum cell sarcoma? Four cases of a lymphoma probably derived from dendritic reticulum cells of the follicular compartment. Histopathology 1982; 6: 269–287
   PubMed Web of Science ®Google Scholar
• Franklin W A, Mason D Y, Pulford K, et al. Immunohistological analysis of human mononuclear phagocytes and dendritic cells by using monoclonal antibodies. Lab Invest 1986; 54: 322–335
   PubMed Web of Science ®Google Scholar
• Monda L, Warnke R, Rosai J. A primary lymph node malignancy with features suggestive of dendritic reticulum cell differentiation. Am J Pathol 1986; 122: 562–572
   PubMed Web of Science ®Google Scholar
• DeVita V T, Jr, Simon R M, Hubbard S M, et al. Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up MOPP treated patients at NCI. Ann Intern Med 1980; 92: 587–595
   PubMed Web of Science ®Google Scholar
• Klimo P, Connors J M. MACOP-B chemotherapy for the treatment of diffuse large cell lymphoma. Ann Intern Med 1985; 102: 596–602
   PubMed Web of Science ®Google Scholar
• Lowenthal D A, Koziner B, Lee B J, et al. The NHL-7: Alternating non-cross resistant combination chemotherapy containing methyl-GAG for diffuse non-Hodgkin's lymphoma. Proc ASCO (abstract) 1987; 6: 197
   Google Scholar